| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | QTRX | Common Stock | Purchase | $1.1M | +105K | +129.91% | $10.43 | 186K | Aug 12, 2022 | Direct | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | The purchase of shares reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with Dr. Toloue's sale of 5,564 shares on June 13, 2022, 432 shares on July 5, 2022 and 446 shares on August 1, 2022, each of which was made to cover taxes upon the vesting of RSUs. Dr. Toloue has agreed to pay Quanterix Corporation $33,350.20, representing the full amount of the profit realized in connection with the short-swing transaction. |
| F2 | This transaction was executed in multiple trades at prices ranging from $10.1101 to $10.50. The price reported reflects the weighted average purchase price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | Includes 67,548 restricted stock units. |